1. Scrip
  2. >>COVID-19

Chloroquine Moves To Top of COVID-19 Clinical Trial List

Bayer, Novartis, Sanofi, Teva And Mylan Donating Antimalarial

 
• By Kevin Grogan

Many hopes for an effective coronavirus treatment are being pinned on chloroquine, not least those of President Trump, and pharma companies are supplying the antimalarial to the US at no cost for use in clinical trials.

Warehouse
Malaria tablets shipped for coronavirus tests • Source: Shutterstock

There is no proof yet that chloroquine is effective in treating COVID-19 but the antimalarial discovered by Bayer AG in 1934 has quickly become the great hope for tackling the symptoms of the coronavirus.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Zelluna Believes Its TCR Tech Can Unlock Natural Killer Cell Potential

 
• By Andrew McConaghie

While CAR-NKs have pivoted towards autoimmune disease, the Norwegian biotech believes its unique platform can deliver in oncology

AstraZeneca COPD Drug Breztri Breezes Through Asthma Trials

 
• By Kevin Grogan

The triple therapy improves lung function in the Phase III KALOS and LOGOS studies

Transient FY26 For Syngene But Momentum In China +1 Projects

 
• By Anju Ghangurde

As biopharma derisks its business with China ‘rebalancing’ strategies, Syngene could convert majority of such pilots into full program contracts amid a challenging FY2025. The CRDMO also expects business discussions pertaining to a newly acquired US biologics site to mature into commercial opportunities.